Abstract
Obesity is a chronic condition of multifactorial etiology characterized by excessive body fat due to a calorie intake higher than energy expenditure. Given the intrinsic limitations of surgical interventions and the difficulties associated with lifestyle changes, pharmacological manipulation is currently one of the main therapies for metabolic diseases. Approaches aiming to promote energy expenditure through induction of thermogenesis have been explored and, in this context, brown adipose tissue (BAT) activation and browning have been shown to be promising strategies. Although such processes are physiologically stimulated by the sympathetic nervous system, not all situations that are known to increase adrenergic signaling promote a concomitant increase in BAT activation or browning in humans. Thus, a better understanding of factors involved in the thermogenesis attributed to these tissues is needed to enable the development of future therapies against obesity. Herein we carry out a critical review of original articles in humans under conditions previously known to trigger adrenergic responses—namely, cold, catecholamine-secreting tumor (pheochromocytoma and paraganglioma), burn injury, and adrenergic agonists—and discuss which of them are associated with increased BAT activation and browning. BAT is clearly stimulated in individuals exposed to cold or treated with high doses of the β3-adrenergic agonist mirabegron, whereas browning is certainly induced in patients after burn injury or with pheochromocytoma, as well as in individuals treated with β3-adrenergic agonist mirabegron for at least 10 weeks. Given the potential effect of increasing energy expenditure, adrenergic stimuli are promising strategies in the treatment of metabolic diseases.
Similar content being viewed by others
Data availability
Not applicable.
Code availability
Not applicable.
References
Arterburn DE, Courcoulas AP (2014) Bariatric surgery for obesity and metabolic conditions in adults. BMJ 349:g3961. https://doi.org/10.1136/bmj.g3961
Leitner BP, Huang S, Brychta RJ, Duckworth CJ, Baskin AS, McGehee S, Tal I, Dieckmann W, Gupta G, Kolodny GM, Pacak K, Herscovitch P, Cypess AM, Chen KY (2017) Mapping of human brown adipose tissue in lean and obese young men. Proc Natl Acad Sci U S A 114(32):8649–8654. https://doi.org/10.1073/pnas.1705287114
Chen KY, Brychta RJ, Abdul Sater Z, Cassimatis TM, Cero C, Fletcher LA, Israni NS, Johnson JW, Lea HJ, Linderman JD, O’Mara AE, Zhu KY, Cypess AM (2020) Opportunities and challenges in the therapeutic activation of human energy expenditure and thermogenesis to manage obesity. J Biol Chem 295(7):1926–1942. https://doi.org/10.1074/jbc.REV119.007363
Fernández-Verdejo R, Marlatt KL, Ravussin E, Galgani JE (2019) Contribution of brown adipose tissue to human energy metabolism. Mol Aspects Med 68:82–89. https://doi.org/10.1016/j.mam.2019.07.003
Marlatt KL, Chen KY, Ravussin E (2018) Is activation of human brown adipose tissue a viable target for weight management? Am J Physiol Regul Integr Comp Physiol 315(3):R479–R483. https://doi.org/10.1152/ajpregu.00443.2017
Yoneshiro T, Aita S, Matsushita M, Okamatsu-Ogura Y, Kameya T, Kawai Y, Miyagawa M, Tsujisaki M, Saito M (2011) Age-related decrease in cold-activated brown adipose tissue and accumulation of body fat in healthy humans. Obesity (Silver Spring) 19(9):1755–1760. https://doi.org/10.1038/oby.2011.125
Yoneshiro T, Aita S, Matsushita M, Kayahara T, Kameya T, Kawai Y, Iwanaga T, Saito M (2013) Recruited brown adipose tissue as an antiobesity agent in humans. J Clin Invest 123(8):3404–3408. https://doi.org/10.1172/JCI67803
Ravussin E, Galgani JE (2011) The implication of brown adipose tissue for humans. Annu Rev Nutr 31:33–47. https://doi.org/10.1146/annurev-nutr-072610-145209
Bhatt PS, Dhillo WS, Salem V (2017) Human brown adipose tissue-function and therapeutic potential in metabolic disease. Curr Opin Pharmacol 37:1–9. https://doi.org/10.1016/j.coph.2017.07.004
Bachman ES, Dhillon H, Zhang CY, Cinti S, Bianco AC, Kobilka BK, Lowell BB (2002) β-AR signaling required for diet-induced thermogenesis and obesity resistance. Science 297(5582):843–845. https://doi.org/10.1126/science.1073160
Asensio C, Jimenez M, Kühne F, Rohner-Jeanrenaud F, Muzzin P (2005) The lack of beta-adrenoceptors results in enhanced insulin sensitivity in mice exhibiting increased adiposity and glucose intolerance. Diabetes 54(12):3490–3495. https://doi.org/10.2337/diabetes.54.12.3490
De Jong JMA, Sun W, Pires ND, Frontini A, Balaz M, Jespersen NZ, Feizi A, Petrovic K, Fischer AW, Bokhari MH, Niemi T, Nuutila P, Cinti S, Nielsen S, Scheele C, Virtanen K, Cannon B, Nedergaard J, Wolfrum C, Petrovic N (2019) Human brown adipose tissue is phenocopied by classical brown adipose tissue in physiologically humanized mice. Nat Metab 1(8):830–843. https://doi.org/10.1038/s42255-019-0101-4
Van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM, Kemerink GJ, Bouvy ND, Schrauwen P, Teule GJ (2009) Cold-activated brown adipose tissue in healthy men. N Engl J Med 360(15):1500–1508. https://doi.org/10.1056/NEJMoa0808718
Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, Taittonen M, Laine J, Savisto NJ, Enerbäck S, Nuutila P (2009) Functional brown adipose tissue in healthy adults. N Engl J Med 360(15):1518–1525. https://doi.org/10.1056/NEJMoa0808949
Saito M, Okamatsu-Ogura Y, Matsushita M, Watanabe K, Yoneshiro T, Nio-Kobayashi J, Iwanaga T, Miyagawa M, Kameya T, Nakada K, Kawai Y, Tsujisaki M (2009) High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 58(7):1526–1531. https://doi.org/10.2337/db09-0530
Yoneshiro T, Aita S, Matsushita M, Kameya T, Nakada K, Kawai Y, Saito M (2011) Brown adipose tissue, whole-body energy expenditure, and thermogenesis in healthy adult men. Obesity (Silver Spring) 19(1):13–16. https://doi.org/10.1038/oby.2010.105
Orava J, Nuutila P, Lidell ME, Oikonen V, Noponen T, Viljanen T, Scheinin M, Taittonen M, Niemi T, Enerbäck S, Virtanen KA (2011) Different metabolic responses of human brown adipose tissue to activation by cold and insulin. Cell Metab 14(2):272–279. https://doi.org/10.1016/j.cmet.2011.06.012
Iwen KA, Backhaus J, Cassens M, Waltl M, Hedesan OC, Merkel M, Heeren J, Sina C, Rademacher L, Windjäger A, Haug AR, Kiefer FW, Lehnert H, Schmid SM (2017) Cold-induced brown adipose tissue activity alters plasma fatty acids and improves glucose metabolism in men. J Clin Endocrinol Metab 102(11):4226–4234. https://doi.org/10.1210/jc.2017-01250
Martinez-Tellez B, Xu H, Sanchez-Delgado G, Acosta FM, Rensen PCN, Llamas-Elvira JM, Ruiz JR (2018) Association of wrist and ambient temperature with cold-induced brown adipose tissue and skeletal muscle [18F]FDG uptake in young adults. Am J Physiol Regul Integr Comp Physiol 315(6):R1281–R1288. https://doi.org/10.1152/ajpregu.00238.2018
Oreskovich SM, Ong FJ, Ahmed BA, Konyer NB, Blondin DP, Gunn E, Singh NP, Noseworthy MD, Haman F, Carpentier AC, Punthakee Z, Steinberg GR, Morrison KM (2019) MRI reveals human brown adipose tissue is rapidly activated in response to cold. J Endocr Soc 3(12):2374–2384. https://doi.org/10.1210/js.2019-00309
Leitner BP, Weiner LS, Desir M, Kahn PA, Selen DJ, Tsang C, Kolodny GM, Cypess AM (2019) Kinetics of human brown adipose tissue activation and deactivation. Int J Obes (Lond) 43(3):633–637. https://doi.org/10.1038/s41366-018-0104-3
Ouellet V, Labbé SM, Blondin DP, Phoenix S, Guérin B, Haman F, Turcotte EE, Richard D, Carpentier AC (2012) Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. J Clin Invest 122(2):545–552. https://doi.org/10.1172/JCI60433
Chondronikola M, Volpi E, Børsheim E, Porter C, Saraf MK, Annamalai P, Yfanti C, Chao T, Wong D, Shinoda K, Labbė SM, Hurren NM, Cesani F, Kajimura S, Sidossis LS (2016) Brown adipose tissue activation is linked to distinct systemic effects on lipid metabolism in humans. Cell Metab 23(6):1200–1206. https://doi.org/10.1016/j.cmet.2016.04.029
Vijgen GH, Bouvy ND, Teule GJ, Brans B, Schrauwen P, Van Marken Lichtenbelt WD (2011) Brown adipose tissue in morbidly obese subjects. PLoS ONE 6(2):e17247. https://doi.org/10.1371/journal.pone.0017247
Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, Tseng YH, Doria A, Kolodny GM, Kahn CR (2009) Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360(15):1509–1517. https://doi.org/10.1056/NEJMoa0810780
Lee P, Smith S, Linderman J, Courville AB, Brychta RJ, Dieckmann W, Werner CD, Chen KY, Celi FS (2014) Temperature-acclimated brown adipose tissue modulates insulin sensitivity in humans. Diabetes 63(11):3686–3698. https://doi.org/10.2337/db14-0513
Blondin DP, Labbé SM, Tingelstad HC, Noll C, Kunach M, Phoenix S, Guérin B, Turcotte EE, Carpentier AC, Richard D, Haman F (2014) Increased brown adipose tissue oxidative capacity in cold-acclimated humans. J Clin Endocrinol Metab 99(3):E438-446. https://doi.org/10.1210/jc.2013-3901
Hanssen MJ, Hoeks J, Brans B, van der Lans AA, Schaart G, van den Driessche JJ, Jörgensen JA, Boekschoten MV, Hesselink MK, Havekes B, Kersten S, Mottaghy FM, van Marken Lichtenbelt WD, Schrauwen P (2015) Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus. Nat Med 21(8):863–865. https://doi.org/10.1038/nm.3891
Hanssen MJ, van der Lans AA, Brans B, Hoeks J, Jardon KM, Schaart G, Mottaghy FM, Schrauwen P, van Marken Lichtenbelt WD (2016) Short-term cold acclimation recruits brown adipose tissue in obese humans. Diabetes 65(5):1179–1189. https://doi.org/10.2337/db15-1372
Yoneshiro T, Matsushita M, Nakae S, Kameya T, Sugie H, Tanaka S, Saito M (2016) Brown adipose tissue is involved in the seasonal variation of cold-induced thermogenesis in humans. Am J Physiol Regul Integr Comp Physiol 310(10):R999–R1009. https://doi.org/10.1152/ajpregu.00057.2015
Senn JR, Maushart CI, Gashi G, Michel R, Lalive d’Epinay M, Vogt R, Becker AS, Müller J, Baláz M, Wolfrum C, Burger IA, Betz MJ (2018) Outdoor temperature influences cold induced thermogenesis in humans. Front Physiol 9:1184. https://doi.org/10.3389/fphys.2018.01184
Muzik O, Mangner TJ, Leonard WR, Kumar A, Janisse J, Granneman JG (2013) 15O PET measurement of blood flow and oxygen consumption in cold-activated human brown fat. J Nucl Med 54(4):523–531. https://doi.org/10.2967/jnumed.112.111336
Blondin DP, Labbé SM, Phoenix S, Guérin B, Turcotte É, Richard D, Carpentier AC, Haman F (2015) Contributions of white and brown adipose tissues and skeletal muscles to acute cold-induced metabolic responses in healthy men. J Physiol 593(3):701–714. https://doi.org/10.1113/jphysiol.2014.283598
Kern PA, Finlin BS, Zhu B, Rasouli N, McGehee RE, Westgate PM, Dupont-Versteegden EE (2014) The effects of temperature and seasons on subcutaneous white adipose tissue in humans: evidence for thermogenic gene induction. J Clin Endocrinol Metab 99(12):E2772-2779. https://doi.org/10.1210/jc.2014-2440
Finlin BS, Memetimin H, Confides AL, Kasza I, Zhu B, Vekaria HJ, Harfmann B, Jones KA, Johnson ZR, Westgate PM, Alexander CM, Sullivan PG, Dupont-Versteegden EE, Kern PA (2018). Human adipose beiging in response to cold and mirabegron. JCI Insight. 3(15). https://doi.org/10.1172/jci.insight.121510
Van der Lans AA, Hoeks J, Brans B, Vijgen GH, Visser MG, Vosselman MJ, Hansen J, Jörgensen JA, Wu J, Mottaghy FM, Schrauwen P, van Marken Lichtenbelt WD (2013) Cold acclimation recruits human brown fat and increases nonshivering thermogenesis. J Clin Invest 123(8):3395–3403. https://doi.org/10.1172/JCI68993
Greaney JL, Kenney WL, Alexander LM (2016) Sympathetic regulation during thermal stress in human aging and disease. Auton Neurosci 196:81–90. https://doi.org/10.1016/j.autneu.2015.11.002
Ludwig J, Gerlich M, Halbrügge T, Graefe KH (1990) The synaptic noradrenaline concentration in humans as estimated from simultaneous measurements of plasma noradrenaline and dihydroxyphenylglycol (DOPEG). J Neural Transm Suppl 32:441–445. https://doi.org/10.1007/978-3-7091-9113-2_60
Erlic Z, Beuschlein F (2019) Metabolic alterations in patients with pheochromocytoma. Exp Clin Endocrinol Diabetes 127(2–03):129–136. https://doi.org/10.1055/a-0649-0960
Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, Lichtenberg TM, Murray BA, Ghayee HK, Else T, Ling S, Jefferys SR, de Cubas AA, Wenz B, Korpershoek E, Amelio AL, Makowski L, Rathmell WK, Gimenez-Roqueplo AP, Giordano TJ, Asa SL, Tischler AS, Pacak K, Nathanson KL, Wilkerson MD, Network CGAR (2017) Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell 31(2):181–193. https://doi.org/10.1016/j.ccell.2017.01.001
Crona J, Taïeb D, Pacak K (2017) New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification. Endocr Rev 38(6):489–515. https://doi.org/10.1210/er.2017-00062
Crona J, Lamarca A, Ghosal S, Welin S, Skogseid B, Pacak K (2019) Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis. Endocr Relat Cancer 26(5):539–550. https://doi.org/10.1530/ERC-19-0024
Hadi M, Chen CC, Whatley M, Pacak K, Carrasquillo JA (2007) Brown fat imaging with (18)F-6-fluorodopamine PET/CT, (18)F-FDG PET/CT, and (123)I-MIBG SPECT: a study of patients being evaluated for pheochromocytoma. J Nucl Med 48(7):1077–1083. https://doi.org/10.2967/jnumed.106.035915
Wang Q, Zhang M, Ning G, Gu W, Su T, Xu M, Li B, Wang W (2011) Brown adipose tissue in humans is activated by elevated plasma catecholamines levels and is inversely related to central obesity. PLoS ONE 6(6):e21006. https://doi.org/10.1371/journal.pone.0021006
Puar T, van Berkel A, Gotthardt M, Havekes B, Hermus AR, Lenders JW, van Marken Lichtenbelt WD, Xu Y, Brans B, Timmers HJ (2016) Genotype-dependent brown adipose tissue activation in patients with pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 101(1):224–232. https://doi.org/10.1210/jc.2015-3205
Abdul Sater Z, Jha A, Hamimi A, Mandl A, Hartley IR, Gubbi S, Patel M, Gonzales M, Taïeb D, Civelek AC, Gharib AM, Auh S, O’Mara AE, Pacak K, Cypess AM (2020). Pheochromocytoma and paraganglioma patients with poor survival often show brown adipose tissue activation. J Clin Endocrinol Metab. 105(4). https://doi.org/10.1210/clinem/dgz314
Frontini A, Vitali A, Perugini J, Murano I, Romiti C, Ricquier D, Guerrieri M, Cinti S (2013) White-to-brown transdifferentiation of omental adipocytes in patients affected by pheochromocytoma. Biochim Biophys Acta 1831(5):950–959. https://doi.org/10.1016/j.bbalip.2013.02.005
Betz MJ, Slawik M, Lidell ME, Osswald A, Heglind M, Nilsson D, Lichtenauer UD, Mauracher B, Mussack T, Beuschlein F, Enerbäck S (2013) Presence of brown adipocytes in retroperitoneal fat from patients with benign adrenal tumors: relationship with outdoor temperature. J Clin Endocrinol Metab 98(10):4097–4104. https://doi.org/10.1210/jc.2012-3535
Di Franco A, Guasti D, Mazzanti B, Ercolino T, Francalanci M, Nesi G, Bani D, Forti G, Mannelli M, Valeri A, Luconi M (2014) Dissecting the origin of inducible brown fat in adult humans through a novel adipose stem cell model from adipose tissue surrounding pheochromocytoma. J Clin Endocrinol Metab 99(10):E1903-1912. https://doi.org/10.1210/jc.2014-1431
Hondares E, Gallego-Escuredo JM, Flachs P, Frontini A, Cereijo R, Goday A, Perugini J, Kopecky P, Giralt M, Cinti S, Kopecky J, Villarroya F (2014) Fibroblast growth factor-21 is expressed in neonatal and pheochromocytoma-induced adult human brown adipose tissue. Metabolism 63(3):312–317. https://doi.org/10.1016/j.metabol.2013.11.014
Nagano G, Ohno H, Oki K, Kobuke K, Shiwa T, Yoneda M, Kohno N (2015) Activation of classical brown adipocytes in the adult human perirenal depot is highly correlated with PRDM16-EHMT1 complex expression. PLoS ONE 10(3):e0122584. https://doi.org/10.1371/journal.pone.0122584
Vergnes L, Davies GR, Lin JY, Yeh MW, Livhits MJ, Harari A, Symonds ME, Sacks HS, Reue K (2016) Adipocyte browning and higher mitochondrial function in periadrenal but not SC fat in pheochromocytoma. J Clin Endocrinol Metab 101(11):4440–4448. https://doi.org/10.1210/jc.2016-2670
Williams FN, Jeschke MG, Chinkes DL, Suman OE, Branski LK, Herndon DN (2009) Modulation of the hypermetabolic response to trauma: temperature, nutrition, and drugs. J Am Coll Surg 208(4):489–502. https://doi.org/10.1016/j.jamcollsurg.2009.01.022
Sommerhalder C, Blears E, Murton AJ, Porter C, Finnerty C, Herndon DN (2020) Current problems in burn hypermetabolism. Curr Probl Surg 57(1):100709. https://doi.org/10.1016/j.cpsurg.2019.100709
Jeschke MG, Chinkes DL, Finnerty CC, Kulp G, Suman OE, Norbury WB, Branski LK, Gauglitz GG, Mlcak RP, Herndon DN (2008) Pathophysiologic response to severe burn injury. Ann Surg 248(3):387–401. https://doi.org/10.1097/SLA.0b013e3181856241
Jeschke MG, Gauglitz GG, Kulp GA, Finnerty CC, Williams FN, Kraft R, Suman OE, Mlcak RP, Herndon DN (2011) Long-term persistance of the pathophysiologic response to severe burn injury. PLoS ONE 6(7):e212450. https://doi.org/10.1371/journal.pone.0021245
Kulp GA, Herndon DN, Lee JO, Suman OE, Jeschke MG (2010) Extent and magnitude of catecholamine surge in pediatric burned patients. Shock 33(4):369–374. https://doi.org/10.1097/SHK.0b013e3181b92340
Stanojcic M, Abdullahi A, Rehou S, Parousis A, Jeschke MG (2018) Pathophysiological response to burn injury in adults. Ann Surg 267(3):576–584. https://doi.org/10.1097/SLA.0000000000002097
Gauglitz GG, Herndon DN, Kulp GA, Meyer WJ, Jeschke MG (2009) Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab 94(5):1656–1664. https://doi.org/10.1210/jc.2008-1947
Wilmore DW, Aulick LH (1978) Metabolic changes in burned patients. Surg Clin North Am 58(6):1173–1187. https://doi.org/10.1016/S0039-6109(16)41685-3
Hart DW, Wolf SE, Mlcak R, Chinkes DL, Ramzy PI, Obeng MK, Ferrando AA, Wolfe RR, Herndon DN (2000) Persistence of muscle catabolism after severe burn. Surgery 128(2):312–319. https://doi.org/10.1067/msy.2000.108059
Kraft R, Herndon DN, Finnerty CC, Hiyama Y, Jeschke MG (2013) Association of postburn fatty acids and triglycerides with clinical outcome in severely burned children. J Clin Endocrinol Metab 98(1):314–321. https://doi.org/10.1210/jc.2012-2599
Sidossis LS, Porter C, Saraf MK, Børsheim E, Radhakrishnan RS, Chao T, Ali A, Chondronikola M, Mlcak R, Finnerty CC, Hawkins HK, Toliver-Kinsky T, Herndon DN (2015) Browning of subcutaneous white adipose tissue in humans after severe adrenergic stress. Cell Metab 22(2):219–227. https://doi.org/10.1016/j.cmet.2015.06.022
Patsouris D, Qi P, Abdullahi A, Stanojcic M, Chen P, Parousis A, Amini-Nik S, Jeschke MG (2015) Burn induces browning of the subcutaneous white adipose tissue in mice and humans. Cell Rep 13(8):1538–1544. https://doi.org/10.1016/j.celrep.2015.10.028
Flores O, Stockton K, Roberts JA, Muller MJ, Paratz JD (2016) The efficacy and safety of adrenergic blockade after burn injury: a systematic review and meta-analysis. J Trauma Acute Care Surg 80(1):146–155. https://doi.org/10.1097/TA.0000000000000887
Lowell BB, Flier JS (1997) Brown adipose tissue, β 3-adrenergic receptors, and obesity. Annu Rev Med 48:307–316. https://doi.org/10.1146/annurev.med.48.1.307
Krief S, Lönnqvist F, Raimbault S, Baude B, Van Spronsen A, Arner P, Strosberg AD, Ricquier D, Emorine LJ (1993) Tissue distribution of beta 3-adrenergic receptor mRNA in man. J Clin Invest 91(1):344–349. https://doi.org/10.1172/JCI116191
Berkowitz DE, Nardone NA, Smiley RM, Price DT, Kreutter DK, Fremeau RT, Schwinn DA (1995) Distribution of β 3 -adrenoceptor mRNA in human tissues. Eur J Pharmacol Mol Pharmacol 289(2):223–228. https://doi.org/10.1016/0922-4106(95)90098-5
Ursino MG, Vasina V, Raschi E, Crema F, De Ponti F (2009) The β3-adrenoceptor as a therapeutic target: current perspectives. Pharmacol Res 59(4):221–234. https://doi.org/10.1016/j.phrs.2009.01.002
Baskin AS, Linderman JD, Brychta RJ, McGehee S, Anflick-Chames E, Cero C, Johnson JW, O’Mara AE, Fletcher LA, Leitner BP, Duckworth CJ, Huang S, Cai H, Garraffo HM, Millo CM, Dieckmann W, Tolstikov V, Chen EY, Gao F, Narain NR, Kiebish MA, Walter PJ, Herscovitch P, Chen KY, Cypess AM (2018) Regulation of human adipose tissue activation, gallbladder size, and bile acid metabolism by a β3-adrenergic receptor agonist. Diabetes 67(10):2113–2125. https://doi.org/10.2337/db18-0462
Peng XR, Gennemark P, O’Mahony G, Bartesaghi S (2015) Unlock the thermogenic potential of adipose tissue: pharmacological modulation and implications for treatment of diabetes and obesity. Front Endocrinol (Lausanne) 6:174. https://doi.org/10.3389/fendo.2015.00174
Buemann B, Toubro S, Astrup A (2000) Effects of the two beta3-agonists, ZD7114 and ZD2079 on 24 hour energy expenditure and respiratory quotient in obese subjects. Int J Obes Relat Metab Disord 24(12):1553–1560. https://doi.org/10.1038/sj.ijo.0801452
Weyer C, Tataranni PA, Snitker S, Danforth E, Ravussin E (1998) Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective β3-adrenoceptor agonist in humans. Diabetes 47(10):1555–1561. https://doi.org/10.2337/diabetes.47.10.1555
Van Baak MA, Hul GB, Toubro S, Astrup A, Gottesdiener KM, DeSmet M, Saris WH (2002) Acute effect of L-796568, a novel β3-adrenergic receptor agonist, on energy expenditure in obese men. Clin Pharmacol Ther 71(4):272–279. https://doi.org/10.1067/mcp.2002.122527
Larsen TM, Toubro S, van Baak MA, Gottesdiener KM, Larson P, Saris WH, Astrup A (2002) Effect of a 28-d treatment with L-796568, a novel β3-adrenergic receptor agonist, on energy expenditure and body composition in obese men. Am J Clin Nutr 76(4):780–788. https://doi.org/10.1093/ajcn/76.4.780
Redman LM, de Jonge L, Fang X, Gamlin B, Recker D, Greenway FL, Smith SR, Ravussin E (2007) Lack of an effect of a novel beta3-adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: a double-blind, placebo-controlled randomized study. J Clin Endocrinol Metab 92(2):527–531. https://doi.org/10.1210/jc.2006-1740
Malik M, van Gelderen EM, Lee JH, Kowalski DL, Yen M, Goldwater R, Mujais SK, Schaddelee MP, de Koning P, Kaibara A, Moy SS, Keirns JJ (2012) Proarrhythmic safety of repeat doses of mirabegron in healthy subjects: a randomized, double-blind, placebo-, and active-controlled thorough QT study. Clin Pharmacol Ther 92(6):696–706. https://doi.org/10.1038/clpt.2012.181
Takasu T, Ukai M, Sato S, Matsui T, Nagase I, Maruyama T, Sasamata M, Miyata K, Uchida H, Yamaguchi O (2007) Effect of (R)-2-(2-aminothiazol-4-yl)-4’-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function. J Pharmacol Exp Ther 321(2):642–647. https://doi.org/10.1124/jpet.106.115840
Cypess AM, Weiner LS, Roberts-Toler C, Franquet Elía E, Kessler SH, Kahn PA, English J, Chatman K, Trauger SA, Doria A, Kolodny GM (2015) Activation of human brown adipose tissue by a β3-adrenergic receptor agonist. Cell Metab 21(1):33–38. https://doi.org/10.1016/j.cmet.2014.12.009
O’Mara AE, Johnson JW, Linderman JD, Brychta RJ, McGehee S, Fletcher LA, Fink YA, Kapuria D, Cassimatis TM, Kelsey N, Cero C, Sater ZA, Piccinini F, Baskin AS, Leitner BP, Cai H, Millo CM, Dieckmann W, Walter M, Javitt NB, Rotman Y, Walter PJ, Ader M, Bergman RN, Herscovitch P, Chen KY, Cypess AM (2020) Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity. J Clin Invest 130(5):2209–2219. https://doi.org/10.1172/JCI131126
Finlin BS, Memetimin H, Zhu B, Confides AL, Vekaria HJ, El Khouli RH, Johnson ZR, Westgate PM, Chen J, Morris AJ, Sullivan PG, Dupont-Versteegden EE, Kern PA (2020) The β3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans. J Clin Invest 130(5):2319–2331. https://doi.org/10.1172/JCI134892
Loh RKC, Formosa MF, La Gerche A, Reutens AT, Kingwell BA, Carey AL (2019) Acute metabolic and cardiovascular effects of mirabegron in healthy individuals. Diabetes Obes Metab 21(2):276–284. https://doi.org/10.1111/dom.13516
Chapple CR, Kaplan SA, Mitcheson D, Klecka J, Cummings J, Drogendijk T, Dorrepaal C, Martin N (2013) Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder. Eur Urol 63(2):296–305. https://doi.org/10.1016/j.eururo.2012.10.048
Nitti VW, Chapple CR, Walters C, Blauwet MB, Herschorn S, Milsom I, Auerbach S, Radziszewski P (2014) Safety and tolerability of the β3 -adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12-week randomised Phase III trials and of a 1-year randomised Phase III trial. Int J Clin Pract 68(8):972–985. https://doi.org/10.1111/ijcp.12433
Blondin DP, Nielsen S, Kuipers EN, Severinsen MC, Jensen VH, Miard S, Jespersen NZ, Kooijman S, Boon MR, Fortin M, Phoenix S, Frisch F, Guérin B, Turcotte É, Haman F, Richard D, Picard F, Rensen PCN, Scheele C, Carpentier AC (2020) Human brown adipocyte thermogenesis is driven by β2-AR stimulation. Cell Metab 32(2):287-300.e287. https://doi.org/10.1016/j.cmet.2020.07.005
Lee P, Day RO, Greenfield JR, Ho KK (2013) Formoterol, a highly β2-selective agonist, increases energy expenditure and fat utilisation in men. Int J Obes (Lond) 37(4):593–597. https://doi.org/10.1038/ijo.2012.90
Onslev J, Jacobson G, Narkowicz C, Backer V, Kalsen A, Kreiberg M, Jessen S, Bangsbo J, Hostrup M (2017) β2-adrenergic stimulation increases energy expenditure at rest, but not during submaximal exercise in active overweight men. Eur J Appl Physiol 117(9):1907–1915. https://doi.org/10.1007/s00421-017-3679-9
Cero C, Lea HJ, Zhu KY, Shamsi F, Tseng YH, Cypess AM (2021). β3-Adrenergic receptors regulate human brown/beige adipocyte lipolysis and thermogenesis. JCI Insight. 6(11). https://doi.org/10.1172/jci.insight.139160
Cannon B, Nedergaard J (2011) Nonshivering thermogenesis and its adequate measurement in metabolic studies. J Exp Biol 214(Pt 2):242–253. https://doi.org/10.1242/jeb.050989
Rossato M, Granzotto M, Macchi V, Porzionato A, Petrelli L, Calcagno A, Vencato J, De Stefani D, Silvestrin V, Rizzuto R, Bassetto F, De Caro R, Vettor R (2014) Human white adipocytes express the cold receptor TRPM8 which activation induces UCP1 expression, mitochondrial activation and heat production. Mol Cell Endocrinol 383(1–2):137–146. https://doi.org/10.1016/j.mce.2013.12.005
Ye L, Wu J, Cohen P, Kazak L, Khandekar MJ, Jedrychowski MP, Zeng X, Gygi SP, Spiegelman BM (2013) Fat cells directly sense temperature to activate thermogenesis. Proc Natl Acad Sci U S A 110(30):12480–12485. https://doi.org/10.1073/pnas.1310261110
Ong FJ, Ahmed BA, Oreskovich SM, Blondin DP, Haq T, Konyer NB, Noseworthy MD, Haman F, Carpentier AC, Morrison KM, Steinberg GR (2018) Recent advances in the detection of brown adipose tissue in adult humans: a review. Clin Sci (Lond) 132(10):1039–1054. https://doi.org/10.1042/CS20170276
Kazak L, Chouchani ET, Jedrychowski MP, Erickson BK, Shinoda K, Cohen P, Vetrivelan R, Lu GZ, Laznik-Bogoslavski D, Hasenfuss SC, Kajimura S, Gygi SP, Spiegelman BM (2015) A creatine-driven substrate cycle enhances energy expenditure and thermogenesis in beige fat. Cell 163(3):643–655. https://doi.org/10.1016/j.cell.2015.09.035
Ikeda K, Kang Q, Yoneshiro T, Camporez JP, Maki H, Homma M, Shinoda K, Chen Y, Lu X, Maretich P, Tajima K, Ajuwon KM, Soga T, Kajimura S (2017) UCP1-independent signaling involving SERCA2b-mediated calcium cycling regulates beige fat thermogenesis and systemic glucose homeostasis. Nat Med 23(12):1454–1465. https://doi.org/10.1038/nm.4429
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pinto, Y.O., Festuccia, W.T.L. & Magdalon, J. The involvement of the adrenergic nervous system in activating human brown adipose tissue and browning. Hormones 21, 195–208 (2022). https://doi.org/10.1007/s42000-022-00361-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42000-022-00361-2